ABSTRACT: Sufiredoxins (Srx) repair the inactivated forms of typical two-Cys peroxiredoxins (Prx) implicated in hydrogen peroxide-mediated cell signaling. The reduction of the cysteine sulfinic acid moiety within the active site of the Prx by Srx involves novel sulfur chemistry and the use of ATP and Mg 2+ . The 1.65 Å crystal structure of human Srx (hSrx) exhibits a new protein fold and a unique nucleotide binding motif containing the Gly98-Cys99-His100-Arg101 sequence at the N-terminus of an R-helix. HPLC analysis of the reaction products has confirmed that the site of ATP cleavage is between theand γ-phosphate groups. Cys99 and the γ-phosphate of ATP, modeled within the active site of the 2.0 Å ADP product complex structure, are adjacent to large surface depressions containing additional conserved residues. These features and the necessity for significant remodeling of the Prx structure suggest that the interactions between hSrx and typical two-Cys Prxs are specific. Moreover, the concave shape of the hSrx active site surface appears to be ideally suited to interacting with the convex surface of the toroidal Prx decamer.
The ubiquitous peroxiredoxins (Prxs) 1 have garnered much attention given the roles of family members in the detoxification of peroxides and the regulation of hydrogen peroxidemediated cellular signaling. Work from several laboratories has shown that these seemingly disparate roles are interrelated despite the differences in peroxide concentrations that are involved. For example, the typical two-Cys Prxs reduce hydrogen peroxide, alkyl hydroperoxides, and peroxynitrite via two conserved cysteine (Cys) residues per active site located on different subunits of an obligate dimer ( Figure  1 ) (1, 2) . The "peroxidatic" Cys residue (Cys-S P H) attacks the O-O bond of the substrate, producing the first product (e.g., H 2 O or ROH) and an oxidized, sulfenic acid (Cys-S P -OH) intermediate. During normal catalysis, the "resolving" Cys residue (Cys-S R H) from the adjacent subunit reacts with the sulfenic acid group to form a disulfide bond. Cellular thiol-containing redox donors such as thioredoxin (Trx) return the Prxs to the activated state through thiol-disulfide exchange reactions (1, 3) . During a transient intracellular burst of peroxide or oxidative stress conditions, the Cys-S P -OH intermediate can react, however, with another molecule of peroxide to yield the inactive, sulfinic acid form (Cys-S P O 2 -) of the Cys-S P H residue ( Figure 1 ) (4-7). The susceptibility of eukaryotic Prxs to this type of inactivation appears to stem from two conserved sequence and structural FIGURE 1: Interrelationships between the catalytic and inactivation pathways of Prxs and the proposed mechanism of Srx. In the top part of the figure, the Cys-S P H and Cys-S R H residues of the Prx dimer (each from one subunit of the dimer; indicated by the divided rectangle) reduce peroxides, e.g., H 2 O 2 , through the formation of a sulfenic acid intermediate (Cys-S P OH) and an intermolecular disulfide bond which is ultimately reduced by a disulfide reductase (1, 2) . Reaction of the Cys-S P OH moiety with another molecule of substrate results in the formation of Cys sulfinic acid (Cys-S P O 2 -) and consequently the inactivation of the Prx molecule. The proposed mechanism of Srx (dashed box) begins with the activation of the sulfinic acid group by reaction with ATP (9) . Additional steps include the thiol-dependent (R-SH) resolution of a sulfinic phosphoryl ester (Cys-S P O 2 PO 3 2-) and thiosulfinate (Prx-Cys-S P O-SCys-Srx) intermediates. The second subunit of the Prx dimer and the Cys-S R H residue are not shown in the Srx mechanism for clarity. See the text for further details. motifs in the vicinity of the active site. The lack of these features in most microorganisms may account, at least in part, for the differing biological roles of Prxs in various organisms (8) .
The ability of the yeast protein sulfiredoxin (Srx1) to repair or retroreduce (a term coined by the Rabilloud group) the yeast two-Cys Prx called Tsa1 (9) was unexpected, as Cys sulfinic and sulfonic acid generation was considered to be biologically irreversible (10, 11) . Purified Srx1 was able to reduce overoxidized Tsa1 in the presence of ATP and Mg 2+ or Mn 2+ (9) . A reductant, either dithiothreitol or thioredoxin, was also required for the reduction of Tsa1-SO 2 -to the Tsa1-SH form. Given the requirement for ATP hydrolysis, generation of a sulfinic phosphoryl ester (Cys-S P O 2 PO 3 2-) intermediate was proposed (Figure 1 ). The inactivity of the Cys84Ser mutant also led Toledano and co-workers to further hypothesize the nucleophilic attack of Cys84-SH of Srx1 on the phosphorylated intermediate, resulting in formation of a thiosulfinate bond (i.e., a disulfide mono-oxide, Prx-Cys-S P O-S-Cys-Srx). Resolution of this complex with a reductant (e.g., Trx or glutathione) in this proposed mechanism would then return both enzymes to their reduced states through putative Prx-Cys-S P OH and Srx1-S-S-R intermediates.
In an effort to discern the molecular basis for the novel sulfur chemistry of Srx and its interactions with Prxs, we have determined the crystal structures of human Srx (hSrx) in complex with phosphate and in complex with ADP, a product of the reaction. The structures reveal a new protein fold and a novel nucleotide binding motif. Biochemical analysis has also confirmed the site of ATP cleavage during the first step of the catalytic reaction. The overall concave shape of the hSrx active site surface suggests that hSrx is ideally suited to interacting with the overoxidized, doughnutlike Prx decamer.
MATERIALS AND METHODS
Human Srx Purification and Crystallization. The fulllength (FL-hSrx, residues 1-137) and engineered (ET-hSrx, residues 32-137) constructs of hSrx were overexpressed in C41(DE3) Escherichia coli using a modified form of the pET19 vector (Novagen, Madison, WI) that contained an N-terminal His tag fusion and an intervening PreScission protease (Amersham Biosciences, Piscataway, NJ) cleavage site. Upon elution of the protein from a nickel affinity resin, 2 mM EDTA, 15 mM DTT, and 10 units of PreScission protease per milligram were added sequentially and incubated overnight at 4°C. Removal of the His tag in each case was verified by mass spectrometry. The resulting proteins contained four additional residues (Gly-Pro-His-Met) at the N-terminus left over from the protease cleavage site. The proteins were further purified and buffer exchanged into 20 mM Hepes (pH 7.5) and 100 mM NaCl by being passed through a HiLoad Superdex 75 gel filtration column. The proteins were concentrated, aliquoted, flash-frozen with liquid nitrogen, and stored at -80°C. FL-hSrx was treated with trypsin (1:50, w/w) to generate the TT construct (TT-hSrx, residues 38-137). The Leu46Met, Leu49Met, Leu82Met triple mutant and the Cys99Ser mutant of ET-hSrx were generated using the QuikChange Site-directed Mutagenesis Kit from Stratagene and the proteins purified in the same manner as the wild-type protein. Selenomethionine (SeMet) was incorporated into the Met triple mutant by the growth of cells in minimal media and the repression of endogenous Met synthesis prior to induction (12) . Crystals of the wildtype and SeMet forms of ET-hSrx were obtained by the vapor diffusion method. Equal volumes of protein [14.5-16 .7 mg/ mL in 20 mM Hepes (pH 7.5) and 100 mM NaCl with or without 5 mM DTT] and well solutions [1 M sodiumpotassium phosphate (pH 8.5) and 6-10% (()-2-methyl-2,4-pentanediol] were mixed and incubated at 20°C for 3-10 days as sitting drops. Cryoprotectant [20% ethylene glycol, 1 M sodium-potassium phosphate (pH 8.5), and 10% (()-2-methyl-2,4-pentanediol] was slowly added to the crystal drop over a 6 h period. Cryoprotectant for the ADPbound structure also contained 200 mM ADP and 10 mM MgCl 2 .
Data Collection and Structure Determination. A threewavelength MAD data set was collected on crystals of the Leu to Met variant of SeMet-labeled ET-hSrx on beamline X12C at the National Synchrotron Light Source (Upton, NY). The crystals exhibited P3 2 21 symmetry (a ) 67.43 Å, b ) 67.43 Å, and c ) 51.07 Å) with one molecule in the asymmetric unit. Native and ADP data sets were collected on an in-house Rigaku/MSC MicroMax-007 generator with a Saturn-92 CCD detector. Data were merged and scaled with d*Trek (Rigaku/MSC, The Woodlands, TX). Three of the four potential selenium sites were found using SOLVE (13) . The phases were improved by solvent flattening and maximum likelihood density modification with RESOLVE (13) . The resulting 1.9 Å electron density maps were unambiguous, and the autobuild feature of RESOLVE was able to generate 91% of the starting model. The chain trace and sequence register were independently verified by examining 1σ and 5σ experimental electron density maps generated by refining the SeMet sites with MLPHARE and solvent flattening with DM within the CCP4 program suite (14, 15) . A comparison of the experimental and composite omit electron density maps facilitated the modification and extension of the model using O (16) and CNS (17) . The SeMet-generated structure was used as the starting model for the molecular replacement solution of the native data set. The native structure required little rebuilding, but we did notice that Cys99, in contrast to the two other data sets, was not oxidized to the sulfinic acid. The native structure was used as the starting model for the ADP complex. At the initial stages of building for the ADP complex, the electron density for the ADP molecule was clearest upon examination of a 3F o -2F c map. The electron density for the ADP molecule gradually improved with refinement. All models were initially refined with CNS using alternating cycles of simulated annealing, positional, and B-factor refinement. The final cycles of refinement were performed with REFMAC5 (18 Oxidation of Human Prx2, DeriVatization of hSrx, and Analysis of Reaction Products. Human Prx2 was recombinantly expressed using the same vector system and expression strain that were used for hSrx. The N-terminal His tag was not removed after the nickel column step. The protein was further purified by being passed through anion exchange (Q Sepharose HP) and size exclusion columns (HiLoad Superdex 200). The protein (20 µM) was oxidized to the sulfinic acid form by incubation (room temperature for 1 h) with a 500-fold molar excess of both H 2 O 2 and dithiothreitol in 20 mM HEPES (pH 7.5) and 100 mM NaCl. This treatment causes redox cycling of the hPrx2 with a fraction of the enzyme being oxidized to the sulfinic acid form during each cycle. The protein was passed back through the Superdex 200 column to remove the excess H 2 O 2 and dithiothreitol. Complete oxidation of hPrx2 to the sulfinic acid form was confirmed by thiol quantitation via reaction with 5,5′-dithiobis(2-nitrobenzoic acid) (20) and mass spectrometry.
A covalently blocked form of Cys99 within ET-hSrx was generated by incubation of the thiol-containing protein with a 10-fold molar excess of iodoacetamide overnight on ice (addition of CH 2 CONH 2 , 57 Da). Complete derivatization was confirmed by mass spectrometry.
The position of ATP cleavage was determined by eluting the reaction products from a Mono Q anion exchange column with a 30 min linear gradient (1 mL/min) from 10 to 500 mM KH 2 PO 4 , brought to pH 6 with KOH, with monitoring at 254 nm. The AMP, ADP, and ATP standards were injected at concentrations of 500 µM each. The sulfiredoxin reaction mixtures contained 25 mM HEPES (pH 8.0), 100 mM NaCl, 500 µM ATP, 1 mM MgCl 2 , 25 µM wild-type, Cys99Ser, or iodoacetamide-derivatized ET-hSrx, and 25 µM overoxidized hPrx2. The reaction mixtures were incubated for 1 h at 37°C. No ATP cleavage was observed for the reaction mixtures from which hSrx or hPrx2 was omitted.
RESULTS AND DISCUSSION
Protein Purification and Crystallization. The full-length human Srx gene (residues 1-137) was cloned into an expression vector (pET19b derivative) that resulted in the addition of an N-terminal poly-His tag followed by an engineered recognition sequence for the PreScission protease (Amersham Biosciences). Treatment of the recombinant hSrx with PreScission protease and dithiothreitol (DTT) released the affinity tag. An analysis of sequence alignments, however, suggested that the N-terminal, glycine-rich sequence (35%; 13 of 37 residues) was unstructured and would prevent crystallization. On the basis of this analysis, the protein was also engineered with an N-terminal truncation up to residue 32 [engineered truncation (ET-hSrx)]. Fulllength hSrx was treated with trypsin in an effort to identify additional sequences at the N-and C-termini that may also need to be removed to facilitate crystallization. From the mass spectrometric analysis of the resulting fragments, the core domain of hSrx [trypsin truncation (TT-hSrx)] contains residues 38-137. Using this approach, 40-100 mg of the hSrx constructs was prepared and screened using the vapor diffusion method of crystallization. All three constructs exhibited similar activity (data not shown). Interestingly, only crystals of ET-hSrx could be obtained (see Materials and Methods). The largest crystals diffracted to 1.5 Å resolution in house and were cryoprotected for data collection at -170°C
by slow equilibration with a mother liquor containing 20% ethylene glycol.
OVerall Topology and ActiVe Site. The structure of EThSrx was determined using the multiwavelength anomalous dispersion (MAD) method and selenomethionine (SeMet) incorporation (21, 22) . To use these methods, however, three conserved Leu residues (Leu36, Leu49, and Leu 82) were mutated to Met since the wild-type, recombinant protein contains only one Met residue left over from the PreScission protease cleavage site. This approach often does not affect protein structure and affords phasing (12) . All three engineered SeMet sites were found during the phasing process using SOLVE (13) . The 1.9 Å MAD-phased experimental electron density map was unambiguous, and RESOLVE was able to autobuild 91% of the model. The chain trace and sequence register were independently verified as described in Materials and Methods.
The SeMet structure was used to determine the 1.65 Å structure of the wild-type protein [R work /R free ) 21.4%/25.8% (Table 1) ] by molecular replacement (Figure 2 ). As briefly mentioned above, crystals could be obtained only for EThSrx. Analysis of the crystal contacts accounts for this phenomenon. Residues 29-37 project away from the core of the protein at a roughly 90°angle to interact through 2-fold symmetry with residues 29-37 of another molecule (see the Supporting Information). Residues 54-59 from a third molecule add to these interactions, forming a three-stranded, antiparallel -sheet. FL-hSrx and TT-hSrx would not be able to form this unusual packing due to steric restrictions and the loss of residues 29-37, respectively.
A DALI (23) search of the available structure database showed that the structure of hSrx represents a new protein fold. The N-terminus of the protein (Figure 2A ) leads into a five-stranded, mixed -sheet. Helix R2 packs against the -sheet with its N-terminus oriented toward the center of the protein. Helices R1 and R3 cap the ends of the structure. The preceding coil structure and helix R2 contain the signature sequence for Srxs, Phe96-Gly/Ser97-Gly98-Cys99-His100-Arg101. This motif in the native structure coordinates a phosphate ion through multiple hydrogen bonding interactions ( Figure 2B ,C). Several water molecules (W1-W3) interact only with the phosphate ion.
The position of Cys99 at the N-terminus of an R-helix is reminiscent of many other proteins that use the R-helix dipole to facilitate biological activity and phosphate binding (reviewed in ref 24) . For example, thioredoxin and its structural homologues, e.g., DsbA and glutaredoxin, all contain a CXXC motif where the first Cys residue is located at the N-terminus of the R-helix. The analysis of model peptides and a wide variety of site-directed mutants support the activation of the thiol group, i.e., the lowering of the pK a by several pH units (25) (26) (27) . In other enzyme systems, e.g., papain and transglutaminase 3, the activated Cys residue is also part of a catalytic triad containing adjacent, noncontiguous His and Asp residues (28, 29) . While there is no apparent biochemical or structural relationship between hSrx and these representative enzyme systems, the R-helix dipole motif most likely serves to activate Cys99 to the thiolate form (see the discussion below). Arg51, which is adjacent to Cys99 (NH2 atom-S γ atom distance of 3.5 Å), may further activate Cys99 as the nucleophile of the reaction. This type of Arg-Cys interaction is also seen in Prxs and methionine sulfoxide reductase B (2, 30) .
ADP Complex, NoVel Nucleotide Binding Motif, and Site of ATP CleaVage. In an effort to determine the mode of binding of ATP to hSrx, the solution bathing the crystals of ET-hSrx was gradually exchanged with a synthetic mother liquor containing ethylene glycol and a potential ligand at 200 mM, either ATP, ADP, or the nonhydrolyzable ATP analogue adenylyl imidodiphosphate (AMPPNP). Data sets were collected and the structures determined by molecular replacement using the wild-type structure as the search model. Only the 2.0 Å ADP complex structure (Table 1) showed convincing electron density for the nucleotide ( Figure  3A) . It is unclear why the electron density for the other nucleotides was not observed, even though one might expect ATP and its analogue AMPPNP to be more likely to displace the phosphate ion present in the active site of the native enzyme. A search for alternative crystallization conditions that do not include phosphate and cocrystallization experiments with the wild type and the inactive Cys99Ser mutant of ET-hSrx with ATP, AMPPNP, and ATP-γS are ongoing.
As mentioned above, the -phosphate group of ADP replaced the phosphate ion seen in the native and SeMet structures via similar interactions with His100 and Arg101 ( Figure 3A) . The occupancy of the ADP molecule was estimated with CNS to be 0.8. This value is consistent with the slightly higher average B-factor value (Table 1 ) and the necessity to displace the phosphate ion found in the active site of the native enzyme structure. Lys61, also a conserved residue, was found to hydrogen bond to an oxygen atom of the R-phosphate group. The only other hydrogen bonds to ADP were from Ser64 and Thr68 to the adenine ring located within a shallow surface depression. A survey of the literature combined with the DALI search results supports the novelty of the Srx nucleotide-binding motif (31, 32) .
The phosphate-nucleotide binding motif of hSrx does, however, show some similarity to protein tyrosine phosphatases and DNA ligases. For example, Srx and protein tyrosine phosphatases (e.g., PTP1B) both contain a conserved Cys residue adjacent to an Arg residue within a phosphatebinding motif. In PTP1B, however, the phosphate binding motif, (H/V)CX 5 R(S/T), replaces the His100 of Srx with several main chain amide groups (33, 34) . ATP-and NAD + -dependent DNA ligases connect two DNA strands through a process in which a conserved Lys residue that interacts with the R-phosphate group becomes adenylated (35, 36) . The presence of the Lys61-R-phosphate interaction in hSrx ( Figure 3A ) prompted us to confirm the nature of ATP cleavage. ET-hSrx was incubated with the sulfinic acid form of recombinant hPrx2 in the presence of ATP and Mg 2+ ( Figure 3B ). The chromatographic separation of the adenosine nucleotide standards and the Srx reaction products indicated that cleavage occurred at the -γ phosphodiester bond and not the R-bond. This observation is the most reasonable given the proximity of the γ-phosphate to Cys99 and the observed loss of activity when the yeast equivalent of Cys99 was mutated to Ser (9) . Moreover, His100 is appropriately placed to stabilize the developing charge on the bridging oxygen atom ( Figure 3A ) (37) . To determine whether ATP hydrolysis was dependent on Cys99, the same reactions were performed with the Cys99Ser mutant of EThSrx and wild-type ET-hSrx pretreated with iodoacetamide. The alkylation and mutation of Cys99 significantly inhibited ATP hydrolysis, suggesting that Cys is involved in this step of the reaction. It may be, however, that even the small alkyl group added to the Cys99 residue or the subtle structural changes in the vicinity of the mutation are significant enough not to allow the Cys-SO 2 -group of the Prx molecule to approach the γ-phosphate of ATP. a Numbers in parentheses refer to the highest-resolution shell: 1.90-1.97 Å for SeMet data, 1.65-1.71 Å for native data, and 2.00-2.07 Å for ADP complex data. b Rsym ) ∑|I -〈I〉|∑I, where I is the observed intensity and 〈I〉 is the average intensity of multiple symmetry-related observations of that reflection. c 〈I〉/〈σ(I)〉 is the rms value of the intensity measurements divided by their estimated standard deviation.
d Rwork ) ∑hkl||Fo| -|Fc||/∑hkl|Fo|, where Fo and Fc are the observed and calculated structure factors, respectively, for the 95% of the data used in refinement.
e Rfree is calculated as described for Rwork with 5% of the data excluded from refinement.
The electron density in the ADP-complexed form of hSrx also showed that Cys99 had been oxidized to the sulfinic acid form (Csd99, Figure 3A) , enabling a direct hydrogen bonding and salt bridge interaction with Arg51. The overoxidation of Cys99 was also observed in the SeMet crystals. In contrast to the native structure which was collected on a freshly grown crystal, the latter structures were determined from older crystals. This observation is similar to that found for DJ-1 (38) . It is unclear at this time whether the oxidation of Cys99 in hSrx has any biological relevance.
Model of the ATP Complex and PutatiVe Interactions with the Prx
Decamer. The hSrx-ADP structure was used to generate an ATP complex model ( Figures 4A and 5) . The γ-phosphate group could only be added to the ADP molecule in one orientation due to stereochemical constraints and potential collisions with active site residues and the other phosphate oxygen atoms. In this model, the γ-phosphate "propeller" makes a hydrogen bonding interaction with the backbone nitrogen atom of Gly98 and is positioned above Cys99 which is located at the bottom of a surface groove. Adjacent to the novel nucleotide binding site are two other pockets that presumably provide contacts to the macromolecular substrate of hSrx, the Prx doughnut-like decamer (1, 2) . The smaller of the pockets is proximal to Cys99 and is lined by residues Arg51-Pro59. This region is separated from a significantly larger pocket by Gly97 and Gly98. Asp80 is prominently positioned within the larger pocket lined by the side chains of Lys116, Tyr128, Asp124, Val127, and Phe96. These features and the coil structures near the active site of Srx (Figure 2A ) may not be as flexible as one might expect on the basis of their surface location. This is in part due to the presence of multiple conserved Pro residues and hydrogen bonding interactions. On the basis of the previous evidence that mammalian and bacterial Prxs undergo dramatic structural changes during catalysis (2, 39) , it is possible that Srx may induce structural changes in the Prx decamer that it is repairing.
The overoxidation of hPrx2 results in the stabilization of the decameric form of the enzyme (40) . The five dimers within the (R 2 ) 5 decamer are arranged such that the active sites are oriented toward the outside of the toroidal structure in a staggered fashion. A closer look at one hPrx2 active site ( Figure 4B ) reveals that the sulfinic acid form of Cys51 (Csd51, Cys-S P O 2 -), located on the N-terminal end of a R-helix, interacts with a conserved residue, Arg127. As described by Wood et al. (8) , the GGLG and YF motifs are present only in peroxide-sensitive, typical two-Cys Prxs, including human Prx1-Prx4. These features are thought to slow the ability of the Cys-S R H residue from the adjacent subunit of the dimer (>13 Å away, Cys172-S R H in hPrx2) to form a disulfide bond with the Cys-S P OH intermediate during the Prx reaction cycle (Figure 1) . Therefore, the sulfenic acid intermediate has more opportunity to react with another substrate molecule, leading to formation of the Cys sulfinic acid and Prx inactivation.
While the unique sequence and structural features of eukaryotic, typical two-Cys Prxs support the molecular basis for peroxide sensitivity and inactivation, they may also impede access to the Cys-S P O 2 -group that is to be repaired by Srx. Given the dimensions of hSrx [∼25 Å × 25 Å × 50 Å ( Figure 4A )], the symmetry and dimensions of the hPrx2 dimer (∼50 Å × 50 Å × 60 Å), and the known compensatory changes that occur in typical two-Cys Prxs during catalysis (2, 39) , a model for how one Srx molecule could bind to each Prx chain of the dimer ( Figure 4C ) was generated. The top panel in Figure 4C illustrates an "edgeon" view of four subunits of the Prx decamer with the obligate dimer shown in the middle. As mentioned above, Figure 1 . Residues highlighted with black lines are strictly conserved. Gly98, Cys99, His100, Arg101, and Lys61 mediate ATP binding. These residues along with Pro52, Asp58, Asp80, and Phe96 may also play a key role in establishing the Srx-Prx macromolecular interface. Other residues that may also contribute to the latter role are highlighted in red: Pro59, Ser64, Thr68, Lys116, Asp124, Val127, and Tyr128. (B) Close-up of the hPrx2 R 2 dimer (purple and yellow chains) on the perimeter of the sulfinic acid form of the hPrx2 decamer (PDB entry 1QMV) (40) . The hydrogen bonds between Csd51 (Cys51-S P O 2 -) and Arg127 stabilize the active site. Nearby within the same chain is the Gly-Gly-Leu-Gly (GGLG) motif (residues 93-96). The Tyr-Phe (YF) motif within the C-terminal helix (residues 187-197) and the resolving Cys residue, Cys172, are contributed from the adjacent subunit of the dimer. the Prx active sites are oriented to the periphery of the decamer. Human Srx could "dock" to the circumference of the Prx doughnut like a belt ( Figure 4C, bottom) . The presence of the noncrystallographic, 2-fold symmetry axis supports the idea that the Srx molecules would have to bind such that their narrow dimensions are adjacent to each other in an antiparallel fashion, with the R1 and R3 helices functioning as molecular calipers. It is unclear whether the Srx molecules will contact each other and adjacent Prx dimers.
An analysis of the putative interface suggests that the displacement of the R-helix containing the Prx YF motif and potentially the GGLG motif are compulsory. The Prx R-helix containing the sulfinic acid group most likely also unwinds as observed in other Prx structures (2) . While it is premature to consider the specific details of the Srx-Prx interactions without a structure of the complex, Asp80 of hSrx ( Figure  4A ) may play a key role in the remodeling of the Prx surface so that Cys99 of hSrx can gain access to the buried Cys-S P O 2 -moiety. It is tempting to speculate that Asp80 disrupts the stable Cys sulfinic acid-Arg interaction [Csd51-Arg127 ( Figure 4B )] of hPrx2 by forming an interaction with Arg127. This interaction may facilitate the local unfolding of the helix containing the Cys-S P O 2 -moiety. Additional residues on the surface of the Prx molecule may be important for Srx binding and catalysis. Chief among these are residues that may interact with the unsatisfied hydrogen-bonding sites of the ATP ribose ring and R-phosphate oxygen atoms ( Figure 3A ) and the small pocket adjacent to Cys99 generated by residues Pro52-Pro59 ( Figure 4A ).
PutatiVe Roles of Srx Residues in the Reaction Mechanism. The crystal structures of hSrx presented herein and the biochemical data from the yeast (9) and human Srxs (41, 42) suggest that the reaction begins with the attack of the Cys-S P O 2 -group on the γ-phosphate of ATP ( Figure 5 ). As described above, however, considerable structural rearrangements most likely take place in the Prx for this step to occur. His100 and Arg101 of the novel nucleotide binding motif, Lys61 (Figure 2B ), and potentially other residues at the PrxSrx macromolecular interface hold the ATP molecule in the correct register for catalysis. His100 most likely functions to stabilize the developing negative charge on the oxygen atom that bridges the -and γ-phosphates. While the nucleotide binding motif of hSrx does remotely resemble the phosphate binding motif of protein tyrosine phosphates, the phosphorylation of Srx as the first step of the reaction seems unlikely given the need to activate the stable sulfinic acid group. This latter possibility, however, cannot be ruled out at this time.
Human Srx can also use GTP, dGTP, or dATP as the phosphate donor in the reaction (41) . This is consistent with the hSrx structure as it can accommodate the functional group differences between ATP and GTP. The ability of hSrx to use the deoxyribose form of the nucleotides also suggests that an interaction with the 2′-oxygen atom is not essential for positioning the ATP molecule for catalysis or mediating the Srx-Prx interface. The role of Mg 2+ in the reaction is not apparent since it was not observed in the ADP crystal structure even though 10 mM MgCl 2 was present during the crystal soaking experiment.
In the Srx mechanism proposed by the Toledano group (Figure 1) , the putative attack on the ATP molecule leads to the formation of a sulfinic acid phosphoryl ester on Prx. This activated intermediate is reminiscent of the activation of a carboxyl group by ATP in a variety of enzyme systems (e.g., glutamine synthase, glutathione synthase, D-Ala:D-Ala ligase, and the peptidoglycan synthetases MurC/MurD) (43) (44) (45) . In these systems, the acyl phosphate intermediate is broken down by the addition of either ammonia or the amine of an amino acid. The observation of DTT-reducible covalent complexes between the yeast Prxs and Srx1 (9) suggests that the activated sulfinic phosphoryl ester intermediate in the Srx reaction is broken down by the nucleophilic attack of the sulfur atom of Cys99 of hSrx. The hSrx crystal structures suggest that the pK a value of Cys99 is lowered by the R-helix dipole and an interaction with Arg51. This proposal is consistent with the pK a of ∼7.3 for hSrx as determined by an iodoacetamide titration (41) . On the basis of the observation that DTT, glutathione (GSH), and Trx can support the reaction (9, 41) , the resulting thiosulfinate (a cystine-Smonoxide) intermediate is broken down by the attack of a thiol on the Cys99 sulfur atom. How GSH and Trx access the buried Cys99 residue in hSrx and in particular the putative Srx-Prx complex is not obvious. Therefore, the apparent inefficiency of hSrx (41) may be a consequence of the structural rearrangements needed to access the sulfinic acid group at the beginning of the reaction, to release Srx from the Srx-Prx intermolecular complex at the end of the reaction, or both.
Biological Implications for Cys-SO 2 -Formation and Repair. Although this area is new to the field of protein repair, there is already some evidence accumulating that Cys sulfinic acid formation and repair in proteins is not uncommon (11) . Indeed, several examples point to functional roles for Cys sulfinic acid formation in the activation of nitrile hydratase (46) and matrix metalloproteinases (47, 48) . The Parkinson's disease protein DJ-1 is thought to be neuroprotective as a consequence of its Cys sulfinic acid-driven mitochondrial targeting (49) . Cys sulfinic acid undoubtedly has additional roles in redox regulation, as well, although only a few in vitro examples exist so far [e.g., glutathione reductase inhibited by treatment with NO carriers (50) , and the neutrophil S100A8 protein treated with hypochlorite (51)]. These observations suggest that Cys sulfinic acid formation in proteins may not just be inhibitory by removing thiols but rather can modulate reactivity in a more direct, functional way (52). While the previous discussion may lead one to believe that hSrx may be a general protein repair enzyme, the new crystal structures presented herein and the biochemical data from the Rhee laboratory suggest the contrary. The novel fold of hSrx generates an extended active site with large surface depressions near the catalytic Cys99 residue ( Figure  4A ). These surface features, the discrete placement of conserved residues, and the apparent need for structural changes within the Prx substrate suggest that the interactions of hSrx with typical two-Cys Prxs (Prx1-Prx4) are specific. This view is supported by the inability of hSrx to repair oxidized human Prx5 (an atypical two-Cys Prx), Prx6 (a oneCys Prx), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (42) . Moreover, hSrx was not able to repair Cys sulfinic acid of the yeast typical two-Cys Prx Tsa1, which is repaired by yeast Srx1, suggesting that species-specific interactions may also be present. The unique 17-amino acid insert found in yeast Srx, between R1 and 3 of hSrx, may be partly responsible for the specific interaction between ySrx and Tsa1.
It will be intriguing to compare the substrate specificity of hSrx with those of the sestrins (Hi95 and PA26) (53) . The sestrins have also been shown to reduce Cys sulfinic acid in a Cys-, ATP-, and Mg 2+ -dependent manner. The sestrins, however, are significantly larger (∼60 kDa) than the Srxs and show no apparent sequence homology. Thus, the sestrins may either preferentially repair the typical twoCys Prxs with currently unknown structural and biochemical motifs or represent a more general repair enzyme. The lack of sestrins within yeast, however, suggests that Srx in this organism may have additional substrates.
CONCLUSION
Human Srx exhibits a new protein fold and a novel nucleotide binding motif containing the consensus Gly-CysHis-Arg sequence. In the first step of the reaction, the ATP molecule is cleaved between the -and γ-phosphate groups. The γ-phosphate of ATP and the essential active site Cys residue are located adjacent to large surface invaginations containing additional conserved residues. These surface features and the known conformational flexibility of the Prxs suggest that specific interactions are made between hSrx and typical two-Cys Prxs. The overall concave shape of the hSrx active site surface also suggests that the repair protein binds to the convex perimeter of the Prx decamer. Additional interactions with adjacent subunits within the decamer may further stabilize the macromolecular interactions.
